In diffuse large B-cell lymphoma (DLBCL), the downregulation of circAPC implied sponging of miR-88 and activation of the oncogene, TET1, ultimately suppressing the Wnt/β-catenin pathways and promoting cell proliferation [40]. Here, TET1 is linked to diffuse large B-cell lymphoma.